Skip to content

Clinical trials

Observational Hematologic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Observational Clear all

160 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20022
20035
20043
20052
20061
20073
20081
20094
20113
20122
20132
20142
20155
20166
201710
20184
20198
202010
202114
20226
20239
202413
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed90
Unknown status30
Recruiting16
Withdrawn6
Enrolling by invitation6
Not yet recruiting6
Active, not recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)23
Assiut University6
Universitaire Ziekenhuizen KU Leuven5
Gruppo Italiano Trapianto di Midollo Osseo4
National Center for Research Resources (NCRR)4
Swedish Orphan Biovitrum4
Rigshospitalet, Denmark3
American Thrombosis and Hemostasis Network2
Assistance Publique - Hôpitaux de Paris2
Beckman Coulter, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases160
Anemia, Sickle Cell14
Neoplasms14
Hemophilia A13
Genetic Diseases, Inborn12
Anemia11
Blood Coagulation Disorders9
Hematologic Neoplasms9
Hemorrhagic Disorders8
Coagulation Protein Disorders7

Trials

Showing 26 to 50 of 160. Each trial links to its page on Pharma Observatory.

60 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.